Influence of pharmaceutical funding on the conclusions of meta-analyses

BMJ 2007; 335 doi: 10.1136/bmj.39381.655845.BE (Published 6 December 2007)
Cite this as: BMJ 2007;335:1167

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL